◀ Back to HLA-A

HLA-A — KIR3DL2

Pathways - manually collected, often from reviews:

• KEGG Antigen processing and presentation: HLA-A/HLA-B/HLA-C/HLA-E/HLA-F/HLA-G → KIR2DL1/KIR2DL2/KIR2DL3/KIR2DL4/KIR2DL5A/KIR2DS1/KIR2DS3/KIR2DS4/KIR2DS5/KIR3DL1/KIR3DL2/KIR3DL3/KLRC1/KLRC2/KLRC3/KLRC4/KLRD1 (protein-protein, activation)
  
• KEGG Natural killer cell mediated cytotoxicity: HLA-A → KIR3DL2 (protein-protein, activation)
• KEGG Graft-versus-host disease: HLA-A/HLA-B/HLA-C/HLA-E/HLA-F/HLA-G → KIR2DL1/KIR2DL2/KIR2DL3/KIR2DL5A/KIR3DL1/KIR3DL2/KLRC1/KLRD1 (protein-protein, missing interaction)
  

Protein-Protein interactions - manually collected from original source literature:

Studies that report less than 10 interactions are marked with *

• IRef Biogrid Interaction: KIR3DL2 — HLA-A (direct interaction, pull down) Döhring et al., J Immunol 1996*
• IRef Hprd Interaction: HLA-A — KIR3DL2 (in vivo) Döhring et al., J Immunol 1996*, Pende et al., J Exp Med 1996*
• IRef Hprd Interaction: HLA-A — KIR3DL2 (in vitro) Döhring et al., J Immunol 1996*, Pende et al., J Exp Med 1996*